Club, pharmacy and pilot project: legal roles in Switzerland
A club, pharmacy and scientific trial have different roles. This comparison explains their legal frameworks without promising prices, waiting times or future eligibility.
At a glance
- Current law, the specific activity and any required authorisations matter. Registration, a laboratory report or a private launch date cannot replace them.
A club name is not an authorisation
An association or membership platform initially describes a private organisation. It does not establish which products the organisation may lawfully offer. An invitation or membership card cannot create a general exception to cannabis law either.
The specific activity under the applicable rules is what matters. A community therefore cannot be equated with an authorised supply of THC cannabis. Claims about an operator need to make that distinction explicit.
| Criterion | Private club | Medical use | Pilot trial | Unauthorised offer |
|---|---|---|---|---|
| Context | Private organisation | Individual treatment | Scientific trial | No established authorisation |
| What the name cannot prove | General THC entitlement | Suitability for everyone | Nationwide market opening | Legality or quality |
A pilot trial has a research framework
Authorised scientific pilot trials are distinct from general market opening. Their rules concern the particular trial. A project’s existence does not establish unrestricted access throughout Switzerland or authorise other operators.
A government authorisation does not automatically mean every participating organisation is government-run either. The responsible operator and actual authorisation matter. The pilot overview explains this research setting; club membership cannot replace its participation requirements.
The medical role is separate
Medical use concerns individual treatment. A treating professional’s responsibility differs from private registration or study participation. Membership alone demonstrates neither a medical indication nor the suitability of a particular product.
Our medical overview explains the Swiss framework. A general online comparison cannot establish a personal treatment decision or guaranteed reimbursement. Prices and waiting times without traceable data would not provide dependable guidance.
THC content and testing cannot settle every legal question
Total THC below 1% is not a general approval for every product category. A sample analysis cannot establish every requirement applying to an offer either. The current legal overview and Swissmedic guide explain the different classifications.
Legal summaries also need to identify the actual conduct. Possessing a small quantity for personal use and consumption are different questions. A blanket statement that “up to 10 grams always means a 100-franc fine” is therefore not a correct summary.
Separating future plans from current rights
Reform debate does not automatically change existing law. Proposals, parliamentary stages and commencement of an adopted rule are different events. A private launch date cannot give an operator legal approval.
When reading an announcement, ask which legal basis is cited, which activity it covers and which document supports the claim. Membership cannot guarantee unconfirmed future THC eligibility under a reform not in force. The reform article explains how to interpret procedural stages carefully.
Official references
Questions about legal roles
- May every cannabis club supply THC?
- The name or association structure does not establish that. The actual legal basis and any required authorisations matter.
- Is an authorised pilot automatically government-run?
- Not merely because it is authorised. Authorisation, responsibility and operation are separate questions.
- Does membership guarantee future THC eligibility?
- No. It creates no statutory entitlement from a reform that is not applicable.
- Does possessing up to 10 grams always mean a 100-franc fine?
- No. Possession of a small quantity for personal use and actual consumption must be distinguished.
We sell only legal Swiss CBD products containing less than 1% THC. THC cannabis is available in Switzerland exclusively through a medical prescription or an approved pilot project. Prices shown come from our own price index and are not third-party offers. Last updated August 2026.